1-3 of 3
Richard B. Bankert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab

Brief Report
Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann, Alexandra M. Livingstone, Jonathan W. Friedberg, Faith Young, Richard I. Fisher, Raymond J. Kelleher, Jr, Richard B. Bankert, Steven H. Bernstein
Journal: Blood
Blood (2009) 113 (16): 3809–3812.
https://doi.org/10.1182/blood-2008-10-185280
Published: 2009
Journal Articles

Follicular Lymphoma Infiltrating CD4 + CD25 + GITR + Regulatory T-Cells Are Potent Suppressors of CD3/CD28 Co-Stimulated Autologous and Allogeneic CD8 + CD25 − and CD4 + CD25 − T-Cells.

Shannon P. Hilchey, PhD, Richard B. Bankert, Ph.D., Lisa M. Rimsza, MD, Steven H. Bernstein, MD
Journal: Blood
Blood (2006) 108 (11): 3681.
https://doi.org/10.1182/blood.V108.11.3681.3681
Published: 2006
Journal Articles

Germ line tumor-associated immunoglobulin V H region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells

Qiang Lou, Raymond J. Kelleher, Jr, Alessandro Sette, Jenni Loyall, Scott Southwood, Richard B. Bankert, Steven H. Bernstein
Journal: Blood
Blood (2004) 104 (3): 752–759.
https://doi.org/10.1182/blood-2004-01-0105
Published: 2004